Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Digital Health Briefs

This article was originally published in The Gray Sheet

Executive Summary

LifeScan blood glucose monitoring system approved; firms form health alliance; and other briefs

You may also be interested in...



UDIs And Adverse Events Draw Attention In Electronic Record Meaningful Use Comments

Organizations such as Pew and the American College of Cardiology focused on the potential of electronic health records to employ unique device identifiers and report adverse events.

Policy Makers Ponder Sending Device Data To Electronic Health Records

In the not-too-distant future, health care providers should be able to accept patient data from blood pressure cuffs, glucose meters and mobile health apps for integration into electronic health records.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031862

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel